Revenue Breakdown
Composition ()
No data
Revenue Streams
Schrodinger Inc (SDGR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Drug discovery services, accounting for 39.1% of total sales, equivalent to $22.88M. Other significant revenue streams include On-premise software and Hosted software. Understanding this composition is critical for investors evaluating how SDGR navigates market cycles within the Software industry.
Profitability & Margins
Evaluating the bottom line, Schrodinger Inc maintains a gross margin of 50.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -83.28%, while the net margin is -102.46%. These profitability ratios, combined with a Return on Equity (ROE) of -30.12%, provide a clear picture of how effectively SDGR converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, SDGR competes directly with industry leaders such as MOMO and CERT. With a market capitalization of $992.29M, it holds a leading position in the sector. When comparing efficiency, SDGR's gross margin of 50.43% stands against MOMO's 37.44% and CERT's 48.26%. Such benchmarking helps identify whether Schrodinger Inc is trading at a premium or discount relative to its financial performance.
